Literature DB >> 12911738

Epithelioid trophoblastic tumor (ETT) initially interpreted as cervical cancer.

F Narita1, K Takeuchi, S Hamana, C Ohbayashi, M Ayata, T Maruo.   

Abstract

The epithelioid trophoblastic tumor (ETT) is a rare form of trophoblastic disease and shows a wide spectrum of differential diagnoses and clinical behavior. A 53-year-old woman presented with ETT presumably originated in spontaneous delivery of 25 years ago and was initially diagnosed as cervical cancer on cervical punch biopsy followed by radical hysterectomy. The uterus showed a small tumor restricted to the cavum with no cervical infiltration, resembling ETT in histologic and immunohistochemical features. The difficulties and clues in distinguishing ETT from nontrophoblastic lesions are discussed.

Entities:  

Mesh:

Year:  2003        PMID: 12911738     DOI: 10.1046/j.1525-1438.2003.13311.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  4 in total

1.  Epithelioid Trophoblastic Tumor in a Postmenopausal Woman: A Case Report.

Authors:  Jung-Woo Park; Jong Woon Bae
Journal:  J Menopausal Med       Date:  2016-04-26

2.  Clinical features and management of trophoblastic epithelioid tumors: A systematic review.

Authors:  Florin Gorun; Larisa Tomescu; Andrei Motoc; Cosmin Citu; Ioan Sas; Denis Mihai Serban; Marius Forga; Ioana Mihaela Citu; Oana Maria Gorun
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

3.  Epithelioid trophoblastic tumor: a case report and review of the literature.

Authors:  Eirwen M Scott; Ashlee L Smith; Mohamed Mokhtar Desouki; Alexander B Olawaiye
Journal:  Case Rep Obstet Gynecol       Date:  2012-12-02

4.  Isolated epithelioid trophoblastic tumor of the vagina: a case report and review of the literature.

Authors:  Jing Zhao; Yang Xiang; Dachun Zhao; Tong Ren; Fengzhi Feng; Xirun Wan
Journal:  Onco Targets Ther       Date:  2013-10-29       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.